508 related articles for article (PubMed ID: 14960498)
21. [Anti-glycolipid antibodies in the diagnosis of autoimmune neuropathies].
Willison HJ
Rev Neurol (Paris); 2002 Dec; 158(123):16-20. PubMed ID: 12690328
[TBL] [Abstract][Full Text] [Related]
22. Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome.
Chiba A; Kusunoki S; Shimizu T; Kanazawa I
Ann Neurol; 1992 Jun; 31(6):677-9. PubMed ID: 1514781
[TBL] [Abstract][Full Text] [Related]
23. [Screening for anti-glycolipid antibody profiles from patients with immune-mediated peripheral neuropathies by Dotzen Ganglio Profile Antibodies].
Caudie C; Reymond A; Antoine JC; Petiot P; Gonnaud PM; Vial C
Ann Biol Clin (Paris); 2006; 64(2):149-56. PubMed ID: 16556525
[TBL] [Abstract][Full Text] [Related]
24. Clinical relevance of the determination of anti-GQ1b antibodies in Miller Fisher and Guillain-Barré syndromes.
Goffette S; Jeanjean A; Pierret F; Peeters A; Sindic CJ
Acta Neurol Belg; 1998 Dec; 98(4):322-6. PubMed ID: 9922819
[TBL] [Abstract][Full Text] [Related]
25. Immunoglobulin G subclass distribution of autoantibodies to gangliosides in patients with Guillain-Barre syndrome.
Ilyas AA; Chen ZW; Cook SD; Mithen FA; Singhal BS
Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):115-23. PubMed ID: 11458979
[TBL] [Abstract][Full Text] [Related]
26. Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies.
Zhang G; Lopez PH; Li CY; Mehta NR; Griffin JW; Schnaar RL; Sheikh KA
Brain; 2004 May; 127(Pt 5):1085-100. PubMed ID: 14985267
[TBL] [Abstract][Full Text] [Related]
27. Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain-Barre syndromes.
Kanzaki M; Kaida K; Ueda M; Morita D; Hirakawa M; Motoyoshi K; Kamakura K; Kusunoki S
J Neurol Neurosurg Psychiatry; 2008 Oct; 79(10):1148-52. PubMed ID: 18339728
[TBL] [Abstract][Full Text] [Related]
28. Anti-GQ1b ganglioside antibody in peripheral nervous system disorders: pathophysiologic role and clinical relevance.
Paparounas K
Arch Neurol; 2004 Jul; 61(7):1013-6. PubMed ID: 15262730
[TBL] [Abstract][Full Text] [Related]
29. Effects of phospholipids on antiganglioside antibody reactivity in GBS.
Hirakawa M; Morita D; Tsuji S; Kusunoki S
J Neuroimmunol; 2005 Feb; 159(1-2):129-32. PubMed ID: 15652411
[TBL] [Abstract][Full Text] [Related]
30. [Anti-GQ1b IgG-negative case of overlapping Fisher's and Gullain-Barré syndromes after Campylobacter jejuni (PEN 19) enteritis].
Hayashi Y; Koga M; Takahashi M; Uchida A; Yuki N
Rinsho Shinkeigaku; 2001 Nov; 41(11):801-4. PubMed ID: 12080613
[TBL] [Abstract][Full Text] [Related]
31. Antibodies against ganglioside complexes in Guillain-Barré syndrome and related disorders.
Kusunoki S; Kaida K
J Neurochem; 2011 Mar; 116(5):828-32. PubMed ID: 21214559
[TBL] [Abstract][Full Text] [Related]
32. Clinical relevance of serum antibodies to GD1b in immune-mediated neuropathies.
Taams NE; Notermans NC; Fokkink WR; Tio-Gillen AP; Huizinga R; Schreurs MWJ; Jacobs BC
J Peripher Nerv Syst; 2018 Dec; 23(4):227-234. PubMed ID: 30101437
[TBL] [Abstract][Full Text] [Related]
33. Anti-ganglioside complex IgM antibodies in multifocal motor neuropathy and chronic immune-mediated neuropathies.
Nobile-Orazio E; Giannotta C; Briani C
J Neuroimmunol; 2010 Feb; 219(1-2):119-22. PubMed ID: 20006388
[TBL] [Abstract][Full Text] [Related]
34. Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry.
Koga M; Gilbert M; Li J; Koike S; Takahashi M; Furukawa K; Hirata K; Yuki N
Neurology; 2005 May; 64(9):1605-11. PubMed ID: 15883324
[TBL] [Abstract][Full Text] [Related]
35. Chronic idiopathic sensory ataxic neuropathy: immunological aspects of a series of 17 patients.
Illa I; Rojas R; Gallardo E; Serrano C; Graus F
Rev Neurol (Paris); 2001 May; 157(5):517-22. PubMed ID: 11438771
[TBL] [Abstract][Full Text] [Related]
36. GQ1b antibody testing in Guillain-Barre syndrome and variants.
Chaudhry F; Gee KE; Vaphiades MS; Biller J; Jay W
Semin Ophthalmol; 2006; 21(4):223-7. PubMed ID: 17182410
[TBL] [Abstract][Full Text] [Related]
37. [A case with upper limb dominant Guillain-Barré syndrome and serum IgG anti-GT1a antibodies: sparing oropharyngeal palsy].
Ogawa K; Hoshino H; Takagi M; Mizoi Y; Irie S; Saito T
Rinsho Shinkeigaku; 2001 Oct; 41(10):679-82. PubMed ID: 11993188
[TBL] [Abstract][Full Text] [Related]
38. Anti-ganglioside antibodies and the presynaptic motor nerve terminal.
Willison HJ; Plomp JJ
Ann N Y Acad Sci; 2008; 1132():114-23. PubMed ID: 18567860
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations.
Goodyear CS; O'Hanlon GM; Plomp JJ; Wagner ER; Morrison I; Veitch J; Cochrane L; Bullens RW; Molenaar PC; Conner J; Willison HJ
J Clin Invest; 1999 Sep; 104(6):697-708. PubMed ID: 10491405
[TBL] [Abstract][Full Text] [Related]
40. [Identification and characterization of a monoclonal IgM reacting with disialylated gangliosides recognizing the CANOMAD syndrome].
Boussaïd I; Bouhour F; Vial C; Caudie C
Ann Biol Clin (Paris); 2011; 69(4):476-80. PubMed ID: 21896416
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
